Bevacizumab (Bev)-based combinations across treatment lines in patients (pts) with metastatic colorectal cancer (mCRC) - interim results from a German non-interventional study (KORALLE)

Eggers E, Uhlig J, Reichert D, Wein A, Schulz H, Beringer A, Arnold D (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 40

Pages Range: 162-163

Authors with CRIS profile

Axel Wein Medizinische Fakultät

Involved external institutions

Kreiskrankenhaus Torgau "Johann Kentmann" DE Germany (DE) CUF Instituto de Oncologia PT Portugal (PT) Roche Deutschland Holding GmbH DE Germany (DE) Medizinische Studiengesellschaft Nord-West GmbH DE Germany (DE)

How to cite

APA:

Eggers, E., Uhlig, J., Reichert, D., Wein, A., Schulz, H., Beringer, A., & Arnold, D. (2017). Bevacizumab (Bev)-based combinations across treatment lines in patients (pts) with metastatic colorectal cancer (mCRC) - interim results from a German non-interventional study (KORALLE). (pp. 162-163).

MLA:

Eggers, E., et al. "Bevacizumab (Bev)-based combinations across treatment lines in patients (pts) with metastatic colorectal cancer (mCRC) - interim results from a German non-interventional study (KORALLE)." 2017. 162-163.

BibTeX: Download